United States · FDA National Drug Code directory
Losartan Potassium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-337_5357e5cd-0f2e-4296-8879-72e700f87d46
- Product NDC
- 59746-337
- Form
- TABLET, FILM COATED
- Composition / generic term
- losartan potassium and hydrochlorothiazide
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121030
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 50 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (59746-337-01) · 59746-337-01
- 1000 TABLET, FILM COATED in 1 BOTTLE (59746-337-10) · 59746-337-10
- 30 TABLET, FILM COATED in 1 BOTTLE (59746-337-30) · 59746-337-30
- 90 TABLET, FILM COATED in 1 BOTTLE (59746-337-90) · 59746-337-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →